4CHUA D T, MA J, SHAM J S, et al. Long- term survival after cisplatin-based induction chemotherapy and radiotherapy for nasopharyngeal carcinoma: a pooled data analysis of two phase Ⅲ trials[J]. J C/in Oncol, 2005, 23(6):1118-1124. 被引量：1
5CHUA D T, MA J ,SHAM J S, et al. Improvement of survival after addition of induction chemotherapy to radiotherapy in patients with early-stage nasopharyngeal carcinoma: a subgroup analysis of two phase Ⅲtrials[J]. IntJ Radiat Oncol Biol Phys, 2006, 65(5):1 300-1306. 被引量：1
6CHAN A T, MA B B, LOY of neoadjuvant carbo followed by radiothe M, et al. Phase Ⅱ study platin and paclitaxel rapy and concurrentcisplatin in patients with Iocoregionally advanced nasopharyngeal carcinoma: therapeutic monitoring with plasma Epstein- Barr virus DNA[J]. J Clin Oncol, 2004, 22(15):3053-3060. 被引量：1
7AL-AMRO A, AL-RAJHI N, KHAFAGA Y, et al. Neoadjuvant chemotherapy followed by concurrent chemo-radiation therapy in locally advanced nasopharyngeal carcinoma[J]. IntJ Radiat Oncol Biol Phys, 2005, 62(2):508-513. 被引量：1
8HUI E P, MA B B, LEUNG S F, et al. Randomized phaseⅡ trial of concurrent cisplatin- radiotherapy with or without neoadjuvant docetaxel and cisplatin in advanced nasopharyngeaf carcinoma[J]. J Clin Oncol, 2009, 27(2):242-249. 被引量：1
9VERMORKEN J B, REMENAR E, VAN HERPEN C, et al. Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer[J]. N EnglJ Med, 2007, 357(17):1695-1704. 被引量：1
10POSNER M R, HERSHOCK D M, BLAJMAN C R, et al. Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer[J]. N EnglJ Med, 2007, 357(1 7):1 705-1 715. 被引量：1
